Journal of Medical Economics
Volume 24, 2021 - Issue 1
Open access
3,273
Views
7
CrossRef citations to date
0
Altmetric
Respiratory Medicine
Cost-effectiveness analysis of anti–IL-5 therapies of severe eosinophilic asthma in Spain
Francisco Javier González-Barcalaa Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain;b Respiratory Medicine, Universidad de Santiago de Compostela, Santiago de Compostela, Spain
, Xavier Muñoz-Gallc Department of Pulmonology, Hospital Universitari Vall d’Hebron, Barcelona, Spain;d CIBER of Respiratory Diseases (CIBERes), Madrid, Spain;e Cell Biology, Physiology, and Immunology, Universidad Autónoma de Barcelona, Barcelona, SpainCorrespondence[email protected]
, Esther Mariscalf GlaxoSmithKline, Madrid, Spain
, Andrea Garcíaf GlaxoSmithKline, Madrid, Spain
, Shibing Yangg GlaxoSmithKline, Collegeville, PA, USA
, Gijs van de Weteringh Pharmerit International, Rotterdam, the Netherlands
& José Luis Izquierdo-Alonsoi Medicine and Specialities Department, Universidad de Alcalá (Alcalá de Henares, Madrid), Hospital Universitario Guadalajara, Guadalajara, Spain
show all
Pages 874-882
|
Received 15 Feb 2021, Accepted 07 Jun 2021, Published online: 14 Jul 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.